Age, Biography and Wiki
Richard Hynes (Richard Olding Hynes) was born on 29 November, 1944 in Massachusetts. Discover Richard Hynes's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 79 years old?
| Popular As |
Richard Olding Hynes |
| Occupation |
N/A |
| Age |
80 years old |
| Zodiac Sign |
Sagittarius |
| Born |
29 November, 1944 |
| Birthday |
29 November |
| Birthplace |
Nairobi, Kenya Colony |
| Nationality |
United States |
We recommend you to check the complete list of Famous People born on 29 November.
He is a member of famous with the age 80 years old group.
Richard Hynes Height, Weight & Measurements
At 80 years old, Richard Hynes height not available right now. We will update Richard Hynes's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Richard Hynes Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Richard Hynes worth at the age of 80 years old? Richard Hynes’s income source is mostly from being a successful . He is from United States. We have estimated
Richard Hynes's net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Richard Hynes Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Hynes served as the president of the American Society for Cell Biology in 2000. He has been a member of the Board of Governors of the Wellcome Trust since 2007. He also served on the Life Sciences jury for the Infosys Prize in 2012.
Hynes received the Gairdner Foundation International Award in 1997. In 2007, the American Society for Cell Biology awarded Hynes and Zena Werb their most prestigious award, the E.B. Wilson Medal. In 2022 he was awarded the Albert Lasker Award for Basic Medical Research.
Hynes received a Guggenheim Fellowship in 1982. He was elected a fellow of the American Academy of Arts and Sciences in 1987, a Fellow of the Royal Society in 1989, a member of the Institute of Medicine in 1995, and a member of the United States National Academy of Sciences in 1996.
Hynes became a faculty member in the biology department at MIT in 1973 and was promoted to full professor in 1983. He was awarded Howard Hughes Medical Institute Investigator status in 1988. He served as the head of the biology department from 1989 to 1991 and as the director of the MIT Center for Cancer Research from 1991 to 2001, and became the Daniel K. Ludwig Professor for Cancer Research and affiliated with the Koch Institute in 1999. Since 2004 he has been an associate member of the Broad Institute.
Hynes earned his B.A. in 1966 and M.A. in 1970 from the University of Cambridge, both in biochemistry. He received his Ph.D. in biology from the Massachusetts Institute of Technology in 1971. He worked as a postdoctoral fellow at the Imperial Cancer Research Fund from 1971 to 1974.
Richard Olding Hynes FRS (born 29 November 1944) is a British biologist, a Howard Hughes Medical Institute Investigator, and the Daniel K. Ludwig Professor for Cancer Research at the Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology. His research focuses on cell adhesion and the interactions between cells and the extracellular matrix, with a particular interest in understanding molecular mechanisms of cancer metastasis. He is well known as a co-discoverer of fibronectin molecules, a discovery that has been listed by Thomson Reuters ScienceWatch as a Nobel Prize candidate.
